Gert Storm
Gert Storm
Unknown affiliation
Verified email at
Cited by
Cited by
Endosomal escape pathways for delivery of biologicals
AK Varkouhi, M Scholte, G Storm, HJ Haisma
Journal of Controlled Release 151 (3), 220-228, 2011
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress
T Lammers, F Kiessling, WE Hennink, G Storm
Journal of controlled release 161 (2), 175-187, 2012
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
RM Schiffelers, A Ansari, J Xu, Q Zhou, Q Tang, G Storm, G Molema, ...
Nucleic acids research 32 (19), e149-e149, 2004
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G Storm, SO Belliot, T Daemen, DD Lasic
Advanced drug delivery reviews 17 (1), 31-48, 1995
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release
C Oerlemans, W Bult, M Bos, G Storm, JFW Nijsen, WE Hennink
Pharmaceutical research 27 (12), 2569-2589, 2010
Theranostic nanomedicine
T Lammers, S Aime, WE Hennink, G Storm, F Kiessling
Accounts of chemical research 44 (10), 1029-1038, 2011
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
JI Hare, T Lammers, MB Ashford, S Puri, G Storm, ST Barry
Advanced drug delivery reviews 108, 25-38, 2017
In situ gelling hydrogels for pharmaceutical and biomedical applications
SR Van Tomme, G Storm, WE Hennink
International journal of pharmaceutics 355 (1-2), 1-18, 2008
Tumour-targeted nanomedicines: principles and practice
T Lammers, WE Hennink, G Storm
British journal of cancer 99 (3), 392-397, 2008
Sheddable coatings for long-circulating nanoparticles
B Romberg, WE Hennink, G Storm
Pharmaceutical research 25 (1), 55-71, 2008
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes
ETM Dams, P Laverman, WJG Oyen, G Storm, GL Scherphof, ...
Journal of Pharmacology and Experimental Therapeutics 292 (3), 1071-1079, 2000
Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe
WJM Mulder, R Koole, RJ Brandwijk, G Storm, PTK Chin, GJ Strijkers, ...
Nano letters 6 (1), 1-6, 2006
Nanotheranostics and image-guided drug delivery: current concepts and future directions
T Lammers, F Kiessling, WE Hennink, G Storm
Molecular pharmaceutics 7 (6), 1899-1912, 2010
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers, GA Koning, TLM ten Hagen, MHAM Fens, AJ Schraa, ...
Journal of Controlled Release 91 (1-2), 115-122, 2003
Specific targeting with poly (ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long …
G Blume, G Cevc, M Crommelin, I Bakker-Woudenberg, C Kluft, G Storm
Biochimica et Biophysica Acta (BBA)-Biomembranes 1149 (1), 180-184, 1993
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status
R van der Meel, LJC Vehmeijer, RJ Kok, G Storm, EVB van Gaal
Intracellular Delivery III, 163-200, 2016
Liposomes: quo vadis?
G Storm, DJA Crommelin
Pharmaceutical Science & Technology Today 1 (1), 19-31, 1998
Liposomes to target the lymphatics by subcutaneous administration
C Oussoren, G Storm
Advanced drug delivery reviews 50 (1-2), 143-156, 2001
Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization
S Hua, MBC De Matos, JM Metselaar, G Storm
Frontiers in pharmacology 9, 790, 2018
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.: II. Influence of liposomal size, lipid composition and lipid dose
C Oussoren, J Zuidema, DJA Crommelin, G Storm
Biochimica et Biophysica Acta (BBA)-Biomembranes 1328 (2), 261-272, 1997
The system can't perform the operation now. Try again later.
Articles 1–20